Theratechnologies – PeptideBlog

Theratechnologies

Theratechnologies

2 registered trials on this site, 0 active. This page lists the trials this organization is registered as lead sponsor of, for the compounds covered on PeptideBlog.net. It is a registry listing, not an assessment of the company or its products.

Compounds covered

Registered trials

TrialCompoundPhaseStatusSponsorEnrolledPrimary completionRegistry updated
TH9507 in Patients With HIV-Associated Lipodystrophy
NCT00123253
TesamorelinPhase 3CompletedTheratechnologies412Nov 2006Nov 27, 2013
TH9507 in Patients With HIV-Associated Lipodystrophy
NCT00435136
TesamorelinPhase 3CompletedTheratechnologies412Nov 2006Nov 27, 2013

Data: ClinicalTrials.gov, U.S. National Library of Medicine. See the full trial tracker.